Cormorant Asset Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-296,712
| Closed | -$4.48M | – | 64 |
|
|
2018
Q4 | $4.48M | Buy |
+296,712
| New | +$4.48M | 0.36% | 45 |
|
|
2017
Q4 | – | Sell |
-100,000
| Closed | -$1.82M | – | 51 |
|
|
2017
Q3 | $1.82M | Sell |
100,000
-130,000
| -57% | -$2.36M | 0.32% | 45 |
|
|
2017
Q2 | $3.57M | Hold |
230,000
| – | – | 0.59% | 44 |
|
|
2017
Q1 | $3.97M | Sell |
230,000
-141,636
| -38% | -$2.45M | 0.58% | 46 |
|
|
2016
Q4 | $4.08M | Hold |
371,636
| – | – | 0.55% | 45 |
|
|
2016
Q3 | $5.83M | Hold |
371,636
| – | – | 0.64% | 47 |
|
|
2016
Q2 | $3.8M | Buy |
371,636
+613
| +0.2% | +$6.26K | 0.54% | 49 |
|
|
2016
Q1 | $4.79M | Hold |
371,023
| – | – | 0.72% | 42 |
|
|
2015
Q4 | $7.74M | Buy |
+371,023
| New | +$7.74M | 0.93% | 36 |
|